Virginia Bio-Connect – The Success of Virginia’s First Statewide Collaborative Life Sciences Initiative

Published on :

Virginia Bio-Connect – The Success of Virginia’s First Statewide Collaborative Life Sciences Initiative By Jelena Ivanjac | January 30, 2024 The end of 2023 marked the completion of Virginia’s first [….]

Weekly Quick Hits (BHCR) – Week of July 24, 2023

Published on :

Children’s Cancer Foundation Awards went out to 11 pediatric cancer researchers in the Baltimore-Washington region, and a number of companies reported their quarterly finances. It was a busy week for life science news in the Capital Region. Here’s a look.

Weekly Quick Hits (BioHealth Capital Region) – Week of July 17, 2023

Published on :

A strong revenue stream is essential for thriving biopharma companies. Despite a struggling economy, several companies within the BioHealth Capital Region are successfully raising capital to support development of new therapeutics for multiple disorders, while others continue to advance their own experimental assets. 

Announcing Your 3rd Annual BioBuzz Awards Finalists

Published on :

We’re excited to announce this year’s finalists for the third annual 2022 BioBuzz Awards. These awards celebrate the people and companies across our regional community and their efforts and accomplishments to impact human health and build a stronger biotech community.

In Conversation: Dr. Amrie Grammer, Co-founder, President and Chief Scientific Officer, AMPEL Biosolutions

Amrie Grammer
Published on :

AMPEL Biosolutions (AMPEL), located in Charlottesville, Virginia is a leading personalized precision medicine company developing tools that can help autoimmune and inflammatory disease patients improve their quality of life. AMPEL is one of the exciting companies that have emerged from the Charlottesville (CVille) biohub clustered around the University of Virginia (UVA). 

Central Virginia Launches New ‘Cluster Accelerator’ Plan to Fast-track Development of Advanced Pharmaceutical Manufacturing

Published on :

Activation Capital, a leading entrepreneurship and ecosystem development organization, announced the launch of a cluster accelerator to catalyze the growth of advanced pharmaceutical manufacturing and R&D in Central Virginia. A coalition of private-public entities from Greater Petersburg and Greater Richmond helped form the accelerator, secured $2.5M in seed funding from GO Virginia and others, and appointed Activation Capital as the organizing entity – a first-of-its-kind initiative for the Commonwealth of Virginia.

Virginia Life Sciences Ecosystem Gets Boost from Essential Medicines-Focused Phlow, Civica Rx

Published on :

The ongoing COVID-19 pandemic greatly exposed a dearth of essential medications and significant vulnerabilities in the United States medical supply chain. Phlow Corporation aims to mitigate those weaknesses and manufacture essential generic medications at its Virginia manufacturing facility.